Reaction
Endometrial Ablation reporting signals
As of the last recalculation, Endometrial Ablation appears in 350 FAERS reports alongside 19 co-occurring drug terms. The strongest observed disproportionality signal is CICLESONIDE (PRR 248.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Ciclesonide | 49 | 248.6 | 249.5 |
| Theophylline Anhydrous | 45 | 247.5 | 248.4 |
| Theophylline | 39 | 227.0 | 227.7 |
| Fluticasone Furoate | 24 | 126.4 | 126.7 |
| Esomeprazole Magnesium Capsule, Delayed Release | 26 | 115.0 | 115.2 |
| Esomeprazole Magnesium Delayed Release Capsules | 26 | 115.0 | 115.2 |
| Esomeprazole Magnesium Dihydrate | 26 | 114.5 | 114.7 |
| Etonogestrel And Ethinyl Estradiol | 35 | 104.2 | 104.3 |
| Ipratropium Bromide | 50 | 97.1 | 97.2 |
| Valsartan And Hydrochlorothiazide | 16 | 73.4 | 73.5 |
| Cetirizine Hydrochloride Allergy | 30 | 64.3 | 64.4 |
| Cetirizine Hydrochloride Tablets | 30 | 64.3 | 64.4 |
| Valsartan Oral | 49 | 62.2 | 62.3 |
| Duloxetine | 46 | 45.0 | 45.1 |
| Fluticasone Propionate And Salmeterol Xinafoate | 40 | 44.6 | 44.6 |
| Conjugated Estrogens | 31 | 34.6 | 34.6 |
| Estrogens, Conjugated | 31 | 34.0 | 34.0 |
| Copper | 15 | 21.6 | 21.6 |
| Leuprolide Acetate | 20 | 16.2 | 16.2 |